Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Nektar Therapeutics stock took a hit Thursday despite test results that suggested its drug has long-term benefits for alopecia patients. The post Nektar Therapeutics Tumbles Despite Long-Term Benefit From Alopecia Drug appeared first on Investor’s Business Daily.
Moderna stock rallied by triple digits when positive news rolled in for its cancer vaccine. But is mRNA ready to return to the limelight? The post Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz appeared first on…
A district judge ruled Wednesday that Liquidia infringed on United Therapeutics’ patents with its drug, Yutrepia. The stocks diverged. The post United Just Pulled The Ultimate Bull Move, As Its Chief Rival Collapsed appeared first on Investor’s Business Daily.
Investors seeking a high yield and stable fundamentals in the healthcare sector need look no further than Bristol Myers Squibb. The post This Pharma Giant Has The Right Medicine For Income Investors appeared first on Investor’s Business Daily.
Eli Lilly already beat its next-generation weight-loss drug, retatrutide, and it hasn’t even hit the market. The post Move Aside Retatrutide, Eli Lilly Just Beat Its Next-Gen Obesity Drug appeared first on Investor’s Business Daily.
After nearly quadrupling over the past month, it’s time to get out of Moderna stock, a Citi analyst said Wednesday as he downgraded shares. The post After Moderna’s Dizzying Rally, It’s Time To Sell, Says Analyst appeared first on Investor’s…
Summit Therapeutics stock catapulted Tuesday after AstraZeneca made a $2 billion investment in the smaller biotech. The post AstraZeneca Pays $2 Billion To Get Into High-Profile Cancer Space appeared first on Investor’s Business Daily.
Uniqure stock plummeted Tuesday on a disappointing four-year update for its experimental gene therapy in patients with Huntington’s disease. The post Uniqure Plummets 40% On Another Shocking Twist For Its Huntington’s Drug appeared first on Investor’s Business Daily.
Here’s a list of all the top-rated growth stocks that have just been added to the IBD 50, IBD Big Cap 20, Sector Leaders, Stock Spotlight and IPO leaders. The post AI Flash Memory Maker Everpure Among 16 Growth Names…
Kodiak Sciences stock skyrocketed Monday on a double win for its potential rivals to Regeneron Pharmaceuticals’ blockbuster eye drug, Eylea. The post Why Regeneron Rival Kodiak Sciences Just Skyrocketed 90%-Plus appeared first on Investor’s Business Daily.
